SlideShare a Scribd company logo
Coronary Artery Disease Mike Dorsch, Pharm.D.,M.S., BCPS
Chronic Disease Symptoms Acute Disease
CAD IHD ACS
CAD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],AHA stats 2011
Pathophysiology ,[object Object],[object Object]
Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical presentation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Definition ,[object Object],[object Object],[object Object]
Classifications ,[object Object],[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object]
HOPE trial 9,297 high-risk patients,  >  55 years old, who had evidence of vascular disease or diabetes plus one other cardiovascular risk factor P<0.001 HOPE Investigators. NEJM 2000;342:145-53.
HOPE trial MI/Stroke/ CV Death CV Death MI Stroke Total Mortality 22% Risk Reduction p<0.001 25% Risk Reduction p<0.001 20% Risk Reduction p=<0.001 31% Risk Reduction p=<0.001 16% Risk  Reduction p=0.006 Non CV Death 0% Risk Reduction p=0.78 HOPE Investigators. NEJM 2000;342:145-53.
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scandinavian Simvastatin Survival Study (4S) Years since randomization % Surviving 30%  risk reduction p = 0.0003 The Lancet, Vol 344, November 19, 1994 4,444 patients with CAD
Scandinavian Simvastatin Survival Study (4S) 11.5% 8.2%
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic stable angina ,[object Object],[object Object]
Antithrombotic Trialists ’ Collaboration Antithrombotic Trialists ’  Collaboration.  BMJ  2002; 324: 71–86. *Vascular events = myocardial infarction, stroke or vascular death Control better Antiplatelet better Category % Odds Reduction Acute myocardial infarction Acute stroke  Prior myocardial infarction  Prior stroke/transient ischemic attack Other high risk Coronary artery disease (e.g. unstable angina, heart failure) Peripheral arterial disease (e.g. intermittent claudication) High risk of embolism (e.g. atrial fibrillation) Other (e.g. diabetes mellitus) All trials 1.0 0.5 0.0 1.5 2.0
Vasospastic angina (Prinzmetal) ,[object Object]
Vasospastic angina (Prinzmetal) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Vasospastic angina (Prinzmetal) ,[object Object],[object Object],[object Object]
Vasospastic angina (Prinzmetal) ,[object Object],[object Object],[object Object]
Questions

More Related Content

What's hot

Managing chest pain- colleague teaching
Managing chest pain- colleague teachingManaging chest pain- colleague teaching
Managing chest pain- colleague teachingRanju Shrestha
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
hawraz Faris
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
evgrace82
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
Dr. Abhimanyu Prashar
 
Non st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable anginaNon st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable anginaGrerk Sutamtewagul
 
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
ISCHEMIC CARDIOPATHY
 
Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014
Nemencio Jr
 
Ischemic heart disease
Ischemic heart disease Ischemic heart disease
Ischemic heart disease
pravisha bhabal
 
Myocardial infarction with case
Myocardial infarction with caseMyocardial infarction with case
Myocardial infarction with case
RABYYA KAUSAR
 
ischemic heart diseases
ischemic heart diseasesischemic heart diseases
ischemic heart diseasesDebika Das
 
Coronary Artery Disease, Angina pectoris, Myocardial Infarction
Coronary Artery Disease, Angina pectoris, Myocardial InfarctionCoronary Artery Disease, Angina pectoris, Myocardial Infarction
Coronary Artery Disease, Angina pectoris, Myocardial Infarction
Jack Frost
 
Presentation 23 5
Presentation 23 5Presentation 23 5
Presentation 23 5
Priyanka K
 
case study on Unstable angina
case study on Unstable anginacase study on Unstable angina
case study on Unstable angina
vasamviharika
 
Thyroid Hormones and Cardiovascular Function and Diseases
Thyroid Hormones and Cardiovascular Function and DiseasesThyroid Hormones and Cardiovascular Function and Diseases
Thyroid Hormones and Cardiovascular Function and Diseases
magdy elmasry
 
Evolving concepts in defining optimal strategies for management of ihd
Evolving concepts in defining optimal strategies for management of ihdEvolving concepts in defining optimal strategies for management of ihd
Evolving concepts in defining optimal strategies for management of ihd
Kyaw Win
 
(Prevention And Control Of Coronary Heart Diseases
(Prevention And Control Of Coronary Heart Diseases(Prevention And Control Of Coronary Heart Diseases
(Prevention And Control Of Coronary Heart DiseasesTamanna Rahman
 
clopidogril and ACS
clopidogril and ACSclopidogril and ACS
clopidogril and ACS
Mahmoud Yossof
 
ueda2011 ak-diabetic cardiomyopathy_d.ali
ueda2011 ak-diabetic cardiomyopathy_d.aliueda2011 ak-diabetic cardiomyopathy_d.ali
ueda2011 ak-diabetic cardiomyopathy_d.ali
ueda2015
 
MYOCARDIAL INFARCTION
MYOCARDIAL INFARCTIONMYOCARDIAL INFARCTION
MYOCARDIAL INFARCTION
Abhay Rajpoot
 

What's hot (20)

Managing chest pain- colleague teaching
Managing chest pain- colleague teachingManaging chest pain- colleague teaching
Managing chest pain- colleague teaching
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 
Non st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable anginaNon st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable angina
 
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
 
Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014Management of Hypertension and Diabetes in Aging People 2014
Management of Hypertension and Diabetes in Aging People 2014
 
Ischemic heart disease
Ischemic heart disease Ischemic heart disease
Ischemic heart disease
 
Myocardial infarction with case
Myocardial infarction with caseMyocardial infarction with case
Myocardial infarction with case
 
ischemic heart diseases
ischemic heart diseasesischemic heart diseases
ischemic heart diseases
 
Coronary Artery Disease, Angina pectoris, Myocardial Infarction
Coronary Artery Disease, Angina pectoris, Myocardial InfarctionCoronary Artery Disease, Angina pectoris, Myocardial Infarction
Coronary Artery Disease, Angina pectoris, Myocardial Infarction
 
Presentation 23 5
Presentation 23 5Presentation 23 5
Presentation 23 5
 
case study on Unstable angina
case study on Unstable anginacase study on Unstable angina
case study on Unstable angina
 
Thyroid Hormones and Cardiovascular Function and Diseases
Thyroid Hormones and Cardiovascular Function and DiseasesThyroid Hormones and Cardiovascular Function and Diseases
Thyroid Hormones and Cardiovascular Function and Diseases
 
Evolving concepts in defining optimal strategies for management of ihd
Evolving concepts in defining optimal strategies for management of ihdEvolving concepts in defining optimal strategies for management of ihd
Evolving concepts in defining optimal strategies for management of ihd
 
(Prevention And Control Of Coronary Heart Diseases
(Prevention And Control Of Coronary Heart Diseases(Prevention And Control Of Coronary Heart Diseases
(Prevention And Control Of Coronary Heart Diseases
 
clopidogril and ACS
clopidogril and ACSclopidogril and ACS
clopidogril and ACS
 
ueda2011 ak-diabetic cardiomyopathy_d.ali
ueda2011 ak-diabetic cardiomyopathy_d.aliueda2011 ak-diabetic cardiomyopathy_d.ali
ueda2011 ak-diabetic cardiomyopathy_d.ali
 
MYOCARDIAL INFARCTION
MYOCARDIAL INFARCTIONMYOCARDIAL INFARCTION
MYOCARDIAL INFARCTION
 
Management of Hypertension
 Management of Hypertension Management of Hypertension
Management of Hypertension
 

Viewers also liked

Bems Kiran presentation1
Bems Kiran presentation1Bems Kiran presentation1
Bems Kiran presentation1
Aamir Sharif
 
Ischaemic heart diseases
Ischaemic heart diseasesIschaemic heart diseases
Ischaemic heart diseases
Tapeshwar Yadav
 
Ischemic heartdisease
Ischemic heartdiseaseIschemic heartdisease
Ischemic heartdiseasembbs138
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
cardiositeindia
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery disease
magdy elmasry
 
Esc guidleines on scad
Esc guidleines on scadEsc guidleines on scad
Esc guidleines on scadKamini Sharma
 
Coronary Artery Disease (CAD)
Coronary Artery Disease (CAD)Coronary Artery Disease (CAD)
Coronary Artery Disease (CAD)
Maria Guia Nelson
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
hus100
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentationTaher Haddad
 

Viewers also liked (12)

Bems Kiran presentation1
Bems Kiran presentation1Bems Kiran presentation1
Bems Kiran presentation1
 
Ischaemic heart diseases
Ischaemic heart diseasesIschaemic heart diseases
Ischaemic heart diseases
 
Ischemic heartdisease
Ischemic heartdiseaseIschemic heartdisease
Ischemic heartdisease
 
Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..Stable ischemic heart disease how is it different from acs..
Stable ischemic heart disease how is it different from acs..
 
stable coronary artery disease
stable coronary artery diseasestable coronary artery disease
stable coronary artery disease
 
Esc guidleines on scad
Esc guidleines on scadEsc guidleines on scad
Esc guidleines on scad
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Coronary Artery Disease (CAD)
Coronary Artery Disease (CAD)Coronary Artery Disease (CAD)
Coronary Artery Disease (CAD)
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 

Similar to CAD

Angina + SOAP note.
Angina + SOAP note.Angina + SOAP note.
Angina + SOAP note.
Norseen Hosameldeen
 
Chronic Stable Angina.pptx
Chronic Stable Angina.pptxChronic Stable Angina.pptx
Chronic Stable Angina.pptx
Mohammad Ali
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
Mohammad Ali
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”
Arindam Pande
 
Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease
ANILKUMAR BR
 
Heart failure – an update [autosaved]
Heart failure – an update [autosaved]Heart failure – an update [autosaved]
Heart failure – an update [autosaved]SMSRAZA
 
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
MosaHasen
 
Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?
Yeong Yeh Lee
 
7. Ischemic heart disease DBU.pptx
7. Ischemic heart disease DBU.pptx7. Ischemic heart disease DBU.pptx
7. Ischemic heart disease DBU.pptx
MisaleHaile
 
Ueda2016 diabetes &amp; peripheral arterial diseases -mamdouh el nahas
Ueda2016 diabetes &amp; peripheral arterial diseases  -mamdouh el nahasUeda2016 diabetes &amp; peripheral arterial diseases  -mamdouh el nahas
Ueda2016 diabetes &amp; peripheral arterial diseases -mamdouh el nahas
ueda2015
 
Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)
The CRUDEM Foundation
 
Heart failure – an update
Heart failure – an updateHeart failure – an update
Heart failure – an update
SMSRAZA
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseZareer Tafadar
 
Angina Pectoris
Angina PectorisAngina Pectoris
Angina Pectoris
Abhay Rajpoot
 
Angina crónica estable - Dr. José Luis López Sendón
Angina crónica estable - Dr. José Luis López SendónAngina crónica estable - Dr. José Luis López Sendón
Angina crónica estable - Dr. José Luis López Sendón
Sociedad Española de Cardiología
 
Outpatient Management of Heart Failure
Outpatient Management of Heart FailureOutpatient Management of Heart Failure
Outpatient Management of Heart Failure
Edgar Hernández
 
Ischemic Heart Disease.ppt
Ischemic Heart Disease.pptIschemic Heart Disease.ppt
Ischemic Heart Disease.pptShama
 
Pfizer Talk Final
Pfizer Talk FinalPfizer Talk Final
Pfizer Talk Final
hospital
 

Similar to CAD (20)

Angina + SOAP note.
Angina + SOAP note.Angina + SOAP note.
Angina + SOAP note.
 
Chronic Stable Angina.pptx
Chronic Stable Angina.pptxChronic Stable Angina.pptx
Chronic Stable Angina.pptx
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
 
Women and Heart Disease
Women and Heart DiseaseWomen and Heart Disease
Women and Heart Disease
 
LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”LDL Cholesterol Target :“ Lower the Better ”
LDL Cholesterol Target :“ Lower the Better ”
 
Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease Coronary artery disease or Ischemic heart disease
Coronary artery disease or Ischemic heart disease
 
Heart failure – an update [autosaved]
Heart failure – an update [autosaved]Heart failure – an update [autosaved]
Heart failure – an update [autosaved]
 
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
6- ACS Dr.Nounnnnnnnnnnnnnnnnnnnnradden Al-Jaber.ppt
 
Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?
 
7. Ischemic heart disease DBU.pptx
7. Ischemic heart disease DBU.pptx7. Ischemic heart disease DBU.pptx
7. Ischemic heart disease DBU.pptx
 
Ueda2016 diabetes &amp; peripheral arterial diseases -mamdouh el nahas
Ueda2016 diabetes &amp; peripheral arterial diseases  -mamdouh el nahasUeda2016 diabetes &amp; peripheral arterial diseases  -mamdouh el nahas
Ueda2016 diabetes &amp; peripheral arterial diseases -mamdouh el nahas
 
Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)Heart Failure (Dr Vosik Presentation)
Heart Failure (Dr Vosik Presentation)
 
Heart failure – an update
Heart failure – an updateHeart failure – an update
Heart failure – an update
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart Disease
 
Angina Pectoris
Angina PectorisAngina Pectoris
Angina Pectoris
 
Chf
ChfChf
Chf
 
Angina crónica estable - Dr. José Luis López Sendón
Angina crónica estable - Dr. José Luis López SendónAngina crónica estable - Dr. José Luis López Sendón
Angina crónica estable - Dr. José Luis López Sendón
 
Outpatient Management of Heart Failure
Outpatient Management of Heart FailureOutpatient Management of Heart Failure
Outpatient Management of Heart Failure
 
Ischemic Heart Disease.ppt
Ischemic Heart Disease.pptIschemic Heart Disease.ppt
Ischemic Heart Disease.ppt
 
Pfizer Talk Final
Pfizer Talk FinalPfizer Talk Final
Pfizer Talk Final
 

Recently uploaded

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 

Recently uploaded (20)

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 

CAD

  • 1. Coronary Artery Disease Mike Dorsch, Pharm.D.,M.S., BCPS
  • 2. Chronic Disease Symptoms Acute Disease
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15. HOPE trial 9,297 high-risk patients, > 55 years old, who had evidence of vascular disease or diabetes plus one other cardiovascular risk factor P<0.001 HOPE Investigators. NEJM 2000;342:145-53.
  • 16. HOPE trial MI/Stroke/ CV Death CV Death MI Stroke Total Mortality 22% Risk Reduction p<0.001 25% Risk Reduction p<0.001 20% Risk Reduction p=<0.001 31% Risk Reduction p=<0.001 16% Risk Reduction p=0.006 Non CV Death 0% Risk Reduction p=0.78 HOPE Investigators. NEJM 2000;342:145-53.
  • 17.
  • 18. Scandinavian Simvastatin Survival Study (4S) Years since randomization % Surviving 30% risk reduction p = 0.0003 The Lancet, Vol 344, November 19, 1994 4,444 patients with CAD
  • 19. Scandinavian Simvastatin Survival Study (4S) 11.5% 8.2%
  • 20.
  • 21.
  • 22.
  • 23. Antithrombotic Trialists ’ Collaboration Antithrombotic Trialists ’ Collaboration. BMJ 2002; 324: 71–86. *Vascular events = myocardial infarction, stroke or vascular death Control better Antiplatelet better Category % Odds Reduction Acute myocardial infarction Acute stroke Prior myocardial infarction Prior stroke/transient ischemic attack Other high risk Coronary artery disease (e.g. unstable angina, heart failure) Peripheral arterial disease (e.g. intermittent claudication) High risk of embolism (e.g. atrial fibrillation) Other (e.g. diabetes mellitus) All trials 1.0 0.5 0.0 1.5 2.0
  • 24.
  • 25.
  • 26.
  • 27.